No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs373356485 |
chr7:38391369-38391370 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs58353432 |
chr7:38391439-38391440 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs575597383 |
chr7:38391468-38391469 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs544545557 |
chr7:38391474-38391475 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs561661606 |
chr7:38391487-38391488 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs574914572 |
chr7:38391516-38391517 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs374153854 |
chr7:38391543-38391544 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs201897035 |
chr7:38391544-38391545 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs3999879 |
chr7:38391547-38391548 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs564185776 |
chr7:38391557-38391558 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs567160886 |
chr7:38391575-38391576 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs529808258 |
chr7:38391578-38391579 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs188724516 |
chr7:38391590-38391591 |
Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs531350952 |
chr7:38391627-38391628 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs548168768 |
chr7:38391636-38391637 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs2735131 |
chr7:38391669-38391670 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs7804460 |
chr7:38391687-38391688 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs547229041 |
chr7:38391688-38391689 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs180750785 |
chr7:38391711-38391712 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs3999880 |
chr7:38391778-38391779 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs558642943 |
chr7:38391787-38391788 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs13308897 |
chr7:38391808-38391809 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs4478467 |
chr7:38391815-38391816 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs558314338 |
chr7:38391817-38391818 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs2540189 |
chr7:38391833-38391834 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs13308903 |
chr7:38391841-38391842 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs143575278 |
chr7:38391845-38391846 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs147892860 |
chr7:38391846-38391847 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs13308908 |
chr7:38391867-38391868 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs577538598 |
chr7:38391873-38391874 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs185197411 |
chr7:38391889-38391890 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs2735130 |
chr7:38391904-38391905 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs367873055 |
chr7:38391968-38391969 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs112637583 |
chr7:38391975-38391976 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs531184453 |
chr7:38392007-38392008 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs372448292 |
chr7:38392037-38392038 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs548212619 |
chr7:38392055-38392056 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs561824095 |
chr7:38392057-38392058 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs375469312 |
chr7:38392058-38392059 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs76201257 |
chr7:38392060-38392061 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs373526216 |
chr7:38392093-38392094 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs117147011 |
chr7:38392105-38392106 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs141664601 |
chr7:38392112-38392113 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs556660898 |
chr7:38392127-38392128 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs58534760 |
chr7:38392144-38392145 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs552231077 |
chr7:38392178-38392179 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs191856510 |
chr7:38392182-38392183 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs141859018 |
chr7:38392203-38392204 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs60962561 |
chr7:38392222-38392223 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs57619846 |
chr7:38392232-38392233 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|